Professor David Weinkove, Chair of the BSRA, on C.elegans research and evidence-led longevity science

Professor David Weinkove, Chair of the BSRA, on C.elegans research and evidence-led longevity science

What can a tiny worm tell us about human ageing, and could gut bacteria hold the key to a longer, healthier life?

In this episode of Beyond Longevity, we sit down with Professor David Weinkove: Chair of the British Society for Research on Ageing (BSRA), Professor at Durham University, and Co-founder and CSO of Magnitude Biosciences. David's lab uses the short-lived nematode C. elegans to run fast, rigorous experiments looking for interventions that extend healthspan and lifespan, and the results are pointing in some surprising directions.

We cover how Prof David moved from physics into experimental molecular biology, how his team discovered that bacterial strains and metabolites can dramatically alter how long worms stay active, and what inhibiting bacterial folate synthesis reveals about the biology of ageing. He also explains how worm movement is a practical proxy for healthspan and why that matters for scaling up research.

The conversation gets into the thornier questions, too: when do you need mice, and when might you skip straight to human-relevant models? How do you fund prevention research when the payoff is decades away? And what are the real risks of mandatory folic acid flour fortification, a policy Prof David argues deserves more scrutiny, given potential microbiome effects we don't yet fully understand.

Prof David also unpacks what the BSRA does day-to-day: from connecting researchers and lobbying government to running small grants and building bridges with clinicians and industry, and why he thinks the longevity field's biggest enemy isn't scepticism, it's overpromising.

Plus, we discover the most extreme longevity idea he's ever come across (involving spare parts — we'll leave it there).

Links:

https://www.durham.ac.uk/staff/david-weinkove/

Home - Magnitude Biosciences

HOME PAGE - BSRA

https://www.linkedin.com/in/david-weinkove-bab807b

In this episode:

00:00 Welcome to Beyond Longevity + Meet Prof. David Weinkove

02:40 From Physics to Bioscience: Career Origins & Model Organisms

04:29 The Breakthrough: How Bacteria (and Folate) Can Extend Worm Lifespan

09:12 Measuring Healthspan in C. elegans: Movement, Decline & New Tech

10:38 Why C. elegans? Fast Ageing, Whole-Organism Biology & Screening Power

12:19 Worms vs Mice: Similarity to Humans, Ethics, Cost & Experimental Variability

15:35 Translating Worm Findings to Humans: Microbiome Links, Exercise Paper & Next Steps

17:52 Funding the Science: UKRI, MRC vs BBSRC, and the Reality of Grant Constraints

20:52 Why Longevity Research Struggles for Support: Messaging, Hype & Prevention

28:39 BSRA’s Mission & the Five Pillars: Public Engagement, Advocacy, Fundraising, Translation

32:01 Breaking Down Silos: Making Longevity Research Useful (and Public)

34:07 Prevention Mindset: Why “Healthier for Longer” Isn’t Instant Gratification

36:15 When to Start Interventions: Metformin, Timing, and Trial Design Challenges

39:39 Why Magnitude Bioscience Exists: Fast Whole-Organism Ageing Screens

41:12 What Companies Test in Worms: From Candidate Drugs to 1,000-Compound Screens

42:48 Folic Acid Fortification & the Microbiome: A Potential Unintended Consequence

45:55 Should Government Engineer Health? Autonomy, Risk, and Public Policy Trade-offs

52:37 Ageing Demographics & the Case for Prevention-First Healthcare Investment

55:59 Making Longevity Matter to Everyday People + Rapid-Fire Q&A

01:01:47 Final Takeaways, Thanks, and Episode Wrap-Up

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(31)

How Much Control Do We Really Have Over Our Health? Spermidine, Autophagy and Patient Empowerment

How Much Control Do We Really Have Over Our Health? Spermidine, Autophagy and Patient Empowerment

At 39, Leslie Kenny was diagnosed with rheumatoid arthritis and lupus and says she was told she had around five years to live. More than two decades later, she is in long-term remission and has turned...

9 Aug 59min

The Hardest Problem in Longevity Is Human Behaviour with Dr Gil Blander, Founder of InsideTracker

The Hardest Problem in Longevity Is Human Behaviour with Dr Gil Blander, Founder of InsideTracker

Nearly two decades ago, Dr Gil Blander was trying to convince investors of an idea that, at the time, sounded radical: blood biomarkers should not only be used to diagnose disease, but to help healthy...

2 Aug 48min

Longevity Medicine Beyond ‘Failure-Based’ Healthcare with Dr Peter Scriven

Longevity Medicine Beyond ‘Failure-Based’ Healthcare with Dr Peter Scriven

In this episode of Beyond Longevity, Daphna speaks with Dr Peter Scriven, Co-Founder and Clinical & Scientific Director of LONGEVITY, about what longevity medicine should actually look like: moving fr...

26 Jul 1h 2min

Longevity at HLTH Why Healthy Ageing Is Finally Going Mainstream

Longevity at HLTH Why Healthy Ageing Is Finally Going Mainstream

In this episode of Beyond Longevity, Daphna speaks with Jody Tropeano Greene, Head of Content at HLTH, and Alexa Mikhail, Senior Content Lead at HLTH US, about how HLTH identifies the healthcare topic...

19 Jul 52min

From Blockbuster Medicine to Extending Healthspan with Sundeep Dugar PhD

From Blockbuster Medicine to Extending Healthspan with Sundeep Dugar PhD

On Beyond Longevity, host Daphna speaks with Dr Sundeep Dugar, PhD, co-founder of BlueOakNx and the scientists behind the blockbuster cholesterol medicines Zetia (ezetimibe) and Vytorin. He explains h...

12 Jul 59min

Robert Gielow on Longevity Products, Pharmacy Access and Consumer Trust with a focus on the German speaking market

Robert Gielow on Longevity Products, Pharmacy Access and Consumer Trust with a focus on the German speaking market

Daphna sat down with Robert Gielow, founder of Mentry Pharma, to discuss what it really takes for foreign supplement and longevity companies to enter the pharmacy markets of Germany, Austria and Switz...

5 Jul 1h

AI, Ageing And The Question Of Trust with Dr Filippo Dall'Armellina

AI, Ageing And The Question Of Trust with Dr Filippo Dall'Armellina

Biology is undergoing one of the biggest transformations in its history. AI is helping researchers analyse enormous datasets, predict protein structures, identify drug targets, and accelerate scientif...

28 Jun 57min

Kyle Holbert on Heavy Metals, Missed Diagnoses and Making Longevity Medicine More Accessible

Kyle Holbert on Heavy Metals, Missed Diagnoses and Making Longevity Medicine More Accessible

Beyond Longevity interviews Kyle Holbert, COO and co-founder of Longevity Centres of America, about how unexplained fatigue, brain fog, depression, anxiety, joint pain and gut issues derailed his heal...

21 Jun 57min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
abels-tarn
liberal-halvtime
romkapsel
jss
rekommandert
vett-og-vitenskap-med-gaute-einevoll
sinnsyn
dekodet-2
villmarksliv
fjellsportpodden
rss-rekommandert
tomprat-med-gunnar-tjomlid
rss-inn-til-kjernen-med-sunniva-rose
rss-nysgjerrige-norge
rss-overskuddsliv
diagnose
abid-nadia-skyld-og-skam
forskningno